Innoviva (INVA) Return on Capital Employed Growth (1y) (2012 - 2026)
Innoviva (INVA) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,805.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 19,453.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,457.00 |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -843.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -843.00 |
| Dec 31, 2025 | -110.00 |
| Sep 30, 2025 | 250.00 |
| Jun 30, 2025 | 607.00 |
| Mar 31, 2025 | 1,382.00 |
| Dec 31, 2024 | 857.00 |
| Sep 30, 2024 | 796.00 |
| Jun 30, 2024 | 1,258.00 |
| Mar 31, 2024 | 488.00 |
| Dec 31, 2023 | 413.00 |
| Sep 30, 2023 | 382.00 |
| Jun 30, 2023 | -2,187.00 |
| Mar 31, 2023 | -3,678.00 |
| Dec 31, 2022 | -3,679.00 |
| Sep 30, 2022 | -3,969.00 |
| Jun 30, 2022 | 522.00 |
| Mar 31, 2022 | 2,450.00 |
| Dec 31, 2021 | 1,468.00 |
| Sep 30, 2021 | 720.00 |
| Jun 30, 2021 | -1,714.00 |